SANT-1, >=98% (HPLC), powder

SANT-1, >=98% (HPLC), powder

Application

Treatment of Anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma cells2 and chronic lymphocytic leukemia cells3 with SANT-1 induced cell death.

Biochem/physiol Actions

SANT-1 is a potent sonic hedgehog pathway (Shh) antagonist that directly inhibits by binding to the smoothened (Smo) receptor. SANT-1 inhibits wild type and oncogenic Smo with equal potency.

SANT-1 inhibited Sonic hedgehog signaling and induced apoptosis via Ras/NF-?B pathway in glioblastoma cells.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Quality Level InChI key InChI Manufacturer Storage Temp. Solubility Form Assay Price Quantity
3573910 SANT-1, >=98% (HPLC), powder 100 FOORCIAZMIWALX-JJIBRWJFSA-N 1S/C23H27N5/c1-19-23(20(2)28(25-19)22-11-7-4-8-12-22)17-24-27-15-13-26(14-16-27)18-21-9-5-3-6-10-21/h3-12,17H,13-16,18H2,1-2H3/b24-17+ SIGMA-ALDRICH −20°C DMSO: 5 mg/mL, clear (warmed) powder ≥98% (HPLC)
£951.32 (exc VAT) per 25MG
-
+
3573911 SANT-1, >=98% (HPLC), powder 100 FOORCIAZMIWALX-JJIBRWJFSA-N 1S/C23H27N5/c1-19-23(20(2)28(25-19)22-11-7-4-8-12-22)17-24-27-15-13-26(14-16-27)18-21-9-5-3-6-10-21/h3-12,17H,13-16,18H2,1-2H3/b24-17+ SIGMA-ALDRICH −20°C DMSO: 5 mg/mL, clear (warmed) powder ≥98% (HPLC)
£236.79 (exc VAT) per 5MG
-
+